ACRS
Aclaris Therapeutics Inc.
$1.91
-$0.04(-2.05%)
40
Overall
--
Value
36
Tech
44
Quality
Market Cap
$199.33M
Volume
2.04M
52W Range
$1.05 - $5.17
Target Price
$7.86
EPS Estimates Overview
| Current Quarter | $-0.13 | Next Quarter | $-0.13 |
| Current Year | $-0.51 | Next Year | $-0.53 |
| QoQ Growth | +0.0% | YoY Growth | -3.9% |
| 3Y EPS CAGR | -2.2% | Target Price | $7.86 |
| Consensus | Buy | Upside | +311.5% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ACRS | $1.91 | -2.1% | 2.04M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Aclaris Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW